Salem Investment Counselors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-7,800
Closed -$123K 1065
2021
Q3
$123K Hold
7,800
0.01% 396
2021
Q2
$169K Hold
7,800
0.01% 346
2021
Q1
$158K Hold
7,800
0.01% 310
2020
Q4
$140K Hold
7,800
0.01% 307
2020
Q3
$91K Buy
+7,800
New +$90.6K 0.01% 319
2019
Q2
Sell
-3,700
Closed -$136K 667
2019
Q1
$136K Buy
+3,700
New +$67.6K 0.01% 218
2018
Q4
Sell
-3,700
Closed -$136K 198
2018
Q3
$136K Hold
3,700
0.01% 218
2018
Q2
$186K Sell
3,700
-900
-20% -$39.7K 0.02% 197
2018
Q1
$166K Sell
4,600
-800
-15% -$24.5K 0.02% 197
2017
Q4
$153K Sell
5,400
-600
-10% -$14.2K 0.02% 210
2017
Q3
$113K Hold
6,000
0.01% 231
2017
Q2
$101K Sell
6,000
-2,000
-25% -$27K 0.01% 250
2017
Q1
$83K Hold
8,000
0.01% 318
2016
Q4
$72K Buy
+8,000
New +$68.9K 0.01% 322

Other funds holding AXGN

Salem Investment Counselors's AXGN Position: Q4 2021 in Review

Salem Investment Counselors sold out of Axogen (AXGN) in Q4 2021, closing a stake of 7,800 shares — an estimated $123K sold.

Salem Investment Counselors first reported a position in AXGN in Q4 2016 and held it in 14 quarters. The position peaked at $186K in Q2 2018. 134 funds tracked by Wall St. Rank hold AXGN as of Q4 2021.

  • Salem Investment Counselors reported no remaining Axogen position as of Q4 2021 after selling out during the quarter.
  • Salem Investment Counselors sold 7,800 Axogen shares in Q4 2021, an estimated $123K.
  • Salem Investment Counselors first reported a position in Axogen in Q4 2016 and held it in 14 quarters.
  • Salem Investment Counselors's Axogen position peaked at $186K in Q2 2018.
  • 134 funds tracked by Wall St. Rank held Axogen as of Q4 2021.

Based on Salem Investment Counselors's 13F filing for Q4 2021, filed 15 Feb 2022.